Key facts
- This page summarizes Suma M. Krishnan's Form 4 filing for Krystal Biotech, Inc. (KRYS).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 10 Nov 2022, 16:05.
Suma M. Krishnan - 08 Nov 2022 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)
- Reporting relationship
- President, R&D, Director, 10%+ Owner
- Issuer ticker
- KRYS
- Reported as of
- 08 Nov 2022
- Net transaction value
- -$143,201
- SEC form
- 4
- Accepted by SEC
- 10 Nov 2022, 16:05:29 UTC
- Prior SEC filing
- 09 Aug 2022
- Next SEC filing
- 28 Nov 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Suma Krishnan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Suma M. Krishnan filed Form 4 for Krystal Biotech, Inc. (KRYS) on 10 Nov 2022.
Change
- Previous filing in this sequence was filed on 09 Aug 2022.
- Current net transaction value: -$143,201.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KRYS
transaction
Common Stock
Sale
- Transaction value
- $65,871
- Shares
- -823
- Change %
- -0.05%
- Price
- $80.04
- Shares after
- 1,726,440
- Date
- 08 Nov 2022
- Ownership
- Direct
- Footnotes
- F1, F2
KRYS
transaction
Common Stock
Sale
- Transaction value
- $77,331
- Shares
- -966
- Change %
- -0.05%
- Price
- $80.05
- Shares after
- 1,787,722
- Date
- 08 Nov 2022
- Ownership
- By Spouse
- Footnotes
- F2, F3, F4, F5
KRYS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 90,000
- Date
- 08 Nov 2022
- Ownership
- By SMK Trust
KRYS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 50,000
- Date
- 08 Nov 2022
- Ownership
- By Krishan Family Trust
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on July 15, 2022 and will terminate on July 15, 2023 and contemplates quarterly sales of 25,000 shares with a limit price of $80.00 per share.
Footnote F2
The transaction was executed in multiple trades ranging from $80.0000 to $80.1900. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Footnote F3
The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Krish Krishnan. The Rule 10b5-1 trading plan adopted by the Reporting Person's spouse started on July 15, 2022 and will terminate on July 15, 2023 and contemplates quarterly sales of 25,000 shares with a limit price of $80.00 per share.
Footnote F4
These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Krish Krishnan.
Footnote F5
Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person.
Footnote F6
Directly beneficially owned by the Krishnan Family Trust. The Reporting Person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.